{"transactions":[{"id":1965372,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T20:13:28.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024."}],"balance_after":8000,"derivative":{"exercise_price":3.83,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001372514-23-000029","document":"wf-form4_167823799654732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000137251423000029/wf-form4_167823799654732.xml","form_type":"4"}},{"id":2413207,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T19:05:09.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023."}],"balance_after":5000,"derivative":{"exercise_price":0.77,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-22-011496","document":"tm225348d8_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000110465922011496/tm225348d8_4.xml","form_type":"4"}},{"id":2881096,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T21:52:21.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2022."}],"balance_after":3333,"derivative":{"exercise_price":6.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001104659-21-011847","document":"tm215262-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000110465921011847/tm215262-5_4seq1.xml","form_type":"4"}},{"id":3262486,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T16:31:50.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become fully exercisable on February 1, 2021."}],"balance_after":3333,"derivative":{"exercise_price":6.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001104659-20-022845","document":"tm209305-5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000110465920022845/tm209305-5_4.xml","form_type":"4"}},{"id":3673780,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T16:39:45.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on February 1, 2020."}],"balance_after":50000,"derivative":{"exercise_price":0.48,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-19-005051","document":"tv512449_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000114420419005051/tv512449_form4.xml","form_type":"4"}},{"id":3868527,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-12T16:55:46.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to all of the shares on July 10, 2019."}],"balance_after":91229,"source":{"system":"sec-edgar","filing":"0001144204-18-038186","document":"tv498477_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000114420418038186/tv498477_4.xml","form_type":"4"}},{"id":3893890,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-06-14T16:20:34.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 12, 2018 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested."}],"balance_after":52500,"derivative":{"exercise_price":2.24,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001485003-18-000092","document":"wf-form4_152900761425185.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500318000092/wf-form4_152900761425185.xml","form_type":"4"}},{"id":4274348,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T16:18:03.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on June 21, 2018."}],"balance_after":15000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-17-033620","document":"v469451_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000114420417033620/v469451_4.xml","form_type":"4"}},{"id":4292510,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-05T19:41:52.000Z","date":"2017-06-02","kind":"exercise","acquired":false,"shares":17570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted an option to purchase these shares pursuant to the Issuer's 2005 Equity Incentive Plan. The option became exercisable immediately at the time of grant."}],"balance_after":0,"derivative":{"exercise_price":0.65,"expiration_date":"2017-07-17","underlying":"Common Stock","underlying_shares":17570},"source":{"system":"sec-edgar","filing":"0001144204-17-031102","document":"v468441_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000114420417031102/v468441_4.xml","form_type":"4"}},{"id":4292509,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T19:41:52.000Z","date":"2017-06-02","kind":"exercise","acquired":true,"shares":17570,"price":0.65,"value":11420.5,"ownership":{"direct":true},"balance_after":41229,"source":{"system":"sec-edgar","filing":"0001144204-17-031102","document":"v468441_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277477/000114420417031102/v468441_4.xml","form_type":"4"}},{"id":4308141,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":115834,"kind":"person","name":"CHANEY PAUL G","position":1,"cik":"0001277477","reported_name":"CHANEY PAUL G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-05-23T16:47:52.000Z","date":"2017-05-19","kind":"grant","acquired":true,"shares":8072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 19, 2017 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested."}],"balance_after":8072,"derivative":{"exercise_price":1.48,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":8072},"source":{"system":"sec-edgar","filing":"0001485003-17-000070","document":"wf-form4_149557245721975.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000148500317000070/wf-form4_149557245721975.xml","form_type":"4"}}]}